is tirzepatide better Weight Loss Blog – Maryland Trim Clinic Weight loss: Semaglutide or tirzepatide,

These were patients who: already had atherosclerotic cardiovascular disease or heart failure were 65 or older or had moderate kidney problems

Who can benefit from GLP-1 receptor agonists

Possible Side Effects: IV therapy is generally safe, with minimal risks such as mild bruising or discomfort at the injection site

doi: 10.1111/j.1582-4934.2011.01451.x

NICE guidelines (NG28) for type 2 diabetes management emphasise individualised treatment approaches, and your clinician can discuss options including other GLP-1 receptor agonists (such as injectable semaglutide or alternative agents like dulaglutide) or different drug classes altogether

Applauding the trial outcomes, Dr V